Status:
COMPLETED
Development and Validation of a Serum Biomarker for the Diagnostic Work-up of Asthma
Lead Sponsor:
KU Leuven
Conditions:
Asthma
Biomarkers
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Serum samples of asthmatic patients will be screened for serum biomarkers
Eligibility Criteria
Inclusion
- 18 - 65 years
- physician-diagnosed asthma
Exclusion
- No clear asthma phenotype
- Presence of other pulmonary diseases (Chronic obstructive pulmonary disease, alfa-1-antitrypsine deficiency emphysema, Immunoglobulin E deficiency, allergic bronchopulmonary aspergillosis)
- \> 15 pack years
- No sputum available
- Respiratory infection
- Other inflammatory diseases (Rheumatoid Arthritis, Colitis Ulcerosa)
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04377958
Start Date
December 1 2016
End Date
May 1 2020
Last Update
May 8 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.